levodopa has been researched along with Coronavirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tipton, PW; Wszolek, ZK | 1 |
| Antonini, A; Chaudhuri, KR; Leta, V; Teo, J | 1 |
2 other study(ies) available for levodopa and Coronavirus Infections
| Article | Year |
|---|---|
What can Parkinson's disease teach us about COVID-19?
Topics: Antiparkinson Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Levodopa; Pandemics; Parkinson Disease; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Outcome of Parkinson's Disease Patients Affected by COVID-19.
Topics: Aged; Aged, 80 and over; Betacoronavirus; Carbidopa; Coronavirus Infections; COVID-19; Female; Humans; Levodopa; Male; Pandemics; Parkinson Disease; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |